Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.58 | $119k | | 06/26/2020 |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.58 | $102.7k | | 06/26/2020 |
05/06/2020 | Neon Therapeutics, Inc. | NTGN | Disposition | Common Stock | 9.7M | $0.00 | $0 | See footnote | 05/06/2020 |
05/06/2020 | Neon Therapeutics, Inc. | NTGN | Disposition | Stock Option (Right to Buy) | 14k | $16.00 | $224k | | 05/06/2020 |
05/06/2020 | Neon Therapeutics, Inc. | NTGN | Disposition | Stock Option (Right to Buy) | 18.5k | $4.64 | $85.8k | | 05/06/2020 |
06/25/2019 | Neon Therapeutics, Inc. | NTGN | Grant | Common Stock | 18.5k | $4.64 | $85.8k | | 06/25/2019 |
06/12/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $4.46 | $70k | | 06/12/2019 |
06/06/2019 | CONSTELLATION PHARMACEUTICALS INC | CNST | Grant | Stock Option (right to buy) | 13.2k | $9.12 | $120.1k | | 06/06/2019 |
06/05/2019 | Allena Pharmaceuticals, Inc. | ALNA | Grant | Stock Option (Right to Buy) | 14k | $5.59 | $78.3k | | 06/05/2019 |
08/22/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Exercise (in-the-money or at-the-money) | Warrant (right to buy) | 51k | $1.55 | $79.1k | By Funds | 08/22/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Common Stock | 2.7M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Purchase | Common Stock | 266.7k | $15.00 | $4M | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series A Preferred Stock | 11M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series B Preferred Stock | 10.6M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series D Preferred Stock | 1.1M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E Preferred Stock | 2.3M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series E-1 Preferred Stock | 3.1M | $0.00 | $0 | By Funds | 07/23/2018 |
07/23/2018 | CONSTELLATION PHARMACEUTICALS INC | CNST | Conversion | Series F Preferred Stock | 1000k | $0.00 | $0 | By Funds | 07/23/2018 |
06/29/2018 | Neon Therapeutics, Inc. | NTGN | Conversion | Series B Preferred Stock | 0 | $0.00 | $0 | See footnote | 06/29/2018 |
06/19/2018 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.92 | $107.3k | | 06/19/2018 |
06/08/2018 | Allena Pharmaceuticals, Inc. | ALNA | Grant | Stock Option (Right to Buy) | 10.2k | $13.52 | $137.7k | | 06/08/2018 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Series B Preferred Stock | 4.6M | $0.00 | $0 | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Series A Preferred Stock | 6.1M | $0.00 | $0 | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Purchase | Common Stock | 215k | $14.00 | $3M | | 11/06/2017 |
11/06/2017 | Allena Pharmaceuticals, Inc. | ALNA | Conversion | Common Stock | 2.6M | $0.00 | $0 | | 11/06/2017 |
07/19/2017 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 13k | $15.00 | $194.4k | | 07/19/2017 |
06/29/2017 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 15k | $16.00 | $240k | | 06/29/2017 |
04/06/2017 | Global Blood Therapeutics, Inc. | GBT | Sale | Common Stock | 31.2k | $33.23 | $1M | | 04/06/2017 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Series A Preferred Stock | 11.2M | $0.00 | $0 | See Footnote | 02/01/2017 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Series A Preferred Stock | 35.8M | $0.00 | $0 | See Footnote | 02/01/2017 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Common Stock | 3M | $0.00 | $0 | See Footnote | 02/01/2017 |
02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Conversion | Common Stock | 9.7M | $0.00 | $0 | See Footnote | 02/01/2017 |